Moore Capital Management, LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Moore Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $2.22 Million - $4.63 Million	-80,856 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $1.63 Million - $2.3 Million	-39,839 Reduced 33.01%	80,856 $4.4 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $1.89 Million - $2.51 Million	50,695 Added 72.42%	120,695 $5.04 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $2.79 Million - $4.69 Million	70,000 New	70,000 $3.07 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.